Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Natural History of Chronic Hepatitis B in Children

소아의 만성 B형 간염의 자연 경과

Kim, Yu-Ri-A;Baek, Seung-Yeon;Eom, Ji-Hyeon;Jeong, Gi-Seop
김유리아;백승연;엄지현;정기섭

  • Published : 20040000
⟨ Previous Next ⟩

Abstract

Purpose:We investigated the spontaneous seroconversion rate of hepatitis B viral markers and predictive factors affecting seroconversion in children with chronic hepatitis B. Methods:The study population included 214 children diagnosed as chronic hepatitis B, with positive HBsAg, HBeAg and HBVDNA over six months, and all patients had a family history of chronic Hepatitis B. They were followed between May 1982 and Febrary 2003 in the Department of Pediatrics, Yonsei University College of Medicine. Serum HBsAg, HBeAg, anti-HBs, HBVDNA, and AST/ALT were measured every six months. Results:The mean age of patients was 7.4$\pm$4.5 years. The loss of HBeAg, HBVDNA and HBsAg were observed in 44(19.2%), 34(15.9%) and 3(1.4%) children respectively. The patients with serum ALT levels over three times normal and with HBVDNA less than 1,000 pg/dL showed significantly higher seroconversion rates of HBeAg and HBVDNA(P<0.001). By analyzing with the life table method, the cumulative seroconversion rate of HBeAg was 11% at 10 and 35% at 19 years of age, while HBVDNA was 9% at 10 and 32% at 19 years of age. In cases of HBsAg, the cumulative seroconversion rate was only 1.5% at 19 years of age. The age of patients, serum ALT and HBVDNA levels were proven as signifincant factors influencing the seroconversion of HBeAg and HBVDNA(P<0.001). Conclusion:In children with chronic hepatitis B, the seroconversion rate of HBeAg and HBVDNA are expected to be 35% and 32%, respectively, by the age of 19 years. The age of patients, serum ALT and HBVDNA levels seem to have significant influence on HBeAg and HBVDNA seroconversion. (Korean J Pediatr 2004;47:282-289)

Keywords

References

  1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet 2002;2:395-403
  2. Maddry WC. Hepatitis B. An important public health issue. Clin Lab 2001;47:51-5
  3. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B antigenemia at birth:A long-term follow-up study. J Pediatr 1998;133:374-7
  4. Choi HJ, Kim YS, Park KS, Lee SI, Moon YM, Kang JK, et al. Clinical study on distribution of hepatitis B virus markers in Korean population. Korean J Gastroenterol 1983;15:163-71
  5. Kim CY, Lee HS, Yim KW. HBsAg＋ and HBsAg－ chronic active hepatitis, liver cirrhrosis and hepatocellular carcinoma in Korea:prevalence and difference in age distribution. Seoul J Med 1992;33:127-31
  6. Joo KR, Bang SJ, Song BC, Youn KH, Joo YH, Yang SH, et al. Hepatitis B viral markers of Korean adults in the late 1990s:Survey data of 70,347 health screenees. Korean J Gastroenterol 1999;33:642-52
  7. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Lee MS, et al. Seroepidermiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 2001;16:153-9
  8. Kim HS, Choi SK, Kim JH, Cho D, Suh SP, Kim SJ. A study of ten-year follow-up for immune responses of plasma derived HB vaccine(Hepavax-B). Korean J Med 1997; 52:48-57
  9. Jeong IS, Chung KS. The Therapeutic Effect of interferon- alpha treatment in children with chronic hepatitis B. J Korean Pediatr Soc 1997;40:955-64
  10. Jun GH, Kim JJ, Shin DH. A survey of HBs antigenemia among healthy primary and Middle School Children, pregnant women in Kyung Pook Province. J Korean Pediatr Soc 1983;26:1118-25
  11. Mc Mahon BJ, Alward WLM, Hall DB. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent developement of the carrier state. J Infect Dis 1985;151:599-603
  12. Chang MH. Natural history of hepatitis B infection in children. J Gastroenterol Hepatol 2000;15(suppl):E11-E19
  13. Giovanna F. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47-58
  14. Liaw YF. Management of chronic hepatitis B-treatment of chronic hepatitis B virus infection:when, who, what for and how. J Gastroenterol Hepatol 2000;15(suppl):E31-3
  15. William ML. Hepatitis B virus infection. New England Journel of Medicine 1997;337:1733-45
  16. Lok ASF, Lai CA. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 1988;8:1130-3
  17. Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B:implications for interferon therapy. J Infect Dis 1997;176:845-50
  18. Bortolotti F, Jara P, Crivellaro C, Hierro L, Cadrobbi P, Frauca E, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29:184-90
  19. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7
  20. Chang MH, Sung JL, Lee CY, Chen CJ, Chen JS, Hsu HY, et al. Factors affection clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989;115:385-90
  21. Yoon JH, Rhee PL, Lee HS, Kim CY. Spontaneous HBeAg clearance rate and its affecting factors in patients with chronic hepatitis B in Korea. Korean J Gastroenterol 1992;24:1313-9
  22. Lee SK, Chung KS. A case of primary hepatocellular carcinoma following vertical transmission of hepatitis B virus in a child. J Korean Pediatr Soc 1991;34:1573-80
  23. Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, et al. Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus. Hepatology 1992;15:770-6
  24. Marx G, Martin SR, Chicoine JF, Alvarez F. Long-term follow up of chronic hepatitis B virus infection in children of different ethinic origins. J Infect Dis 2002;186:295-301
  25. Alter MJ. Epidermiology and prevention of hepatitis B. Semin Liver Dis 2003;23:39-46
  26. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis 2003;23:21-37
  27. Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992;15:382-6
  28. Lee PI, Chang MH, Lee CY, Hsu HY, Chen JS, Chen PJ, et al. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology 1990;12:657-62
  29. Chang MH, Hsu HC, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B antigen seroconversion in childhood:with special emphasis on the clearance of hepatitis B e antigen before three years of age. Hepatology 1995;22:1387-92
  30. Lok ASF, Lai CL, Wu PC, Leung EKY, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987;92:1839-43
  31. Bortolotti F, Cadrobbi M, Crivellaro C, Guido M, Rugge M, Noventa F, et al. Long-term outcome of chronic type B hepatitis in patients who acquired hepatitis B virus infection in childhood. Gastroenterology 1990;99:805-10
  32. Yuen MF, Lai CL. Treatment of chronic hepatitis B. Lancet 2001;1:232-41
  33. Kim JK, Park YH, Chung WY, Kim CH. Mutations in hepatitis B virus precore and core promotor in children with chronic hepatitis B infection - comparison between vertical and non-vertical transmission. J Korean Pediatr Soc 2000;43:779-91
  34. Chang MH, Hsu HY, Ni YH, Tsai KS, Lee PI, Chen PJ, et al. Precore stop codon mutant in chronic hepatitis B virus infection in children:its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen. J Hepatol 1998;28:915-22